PFG Investments’s Tonix Pharmaceuticals TNXP Stock Holding History

PFG Investments’s Portfolio TNXP Stock Details TNXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-2,180	Closed	-$71.9K	–	1098
2024 Q4	$71.9K	Buy	+2,180	New	+$45.3K	﹤0.01%	964

Other funds holding TNXP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

CIAM

Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

CIBC Asset Management Toronto, Ontario, Canada $45.6B AUM 44.74% 1-Year Est. Return

PFG Investments's TNXP Position: Q1 2025 in Review

PFG Investments sold out of Tonix Pharmaceuticals (TNXP) in Q1 2025, closing a stake of 2,180 shares — an estimated $71.9K sold.

PFG Investments first reported a position in TNXP in Q4 2024 and held it in 1 quarter. The position peaked at $71.9K in Q4 2024. 26 funds tracked by Wall St. Rank hold TNXP as of Q1 2025.

PFG Investments reported no remaining Tonix Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
PFG Investments sold 2,180 Tonix Pharmaceuticals shares in Q1 2025, an estimated $71.9K.
PFG Investments first reported a position in Tonix Pharmaceuticals in Q4 2024 and held it in 1 quarter.
PFG Investments's Tonix Pharmaceuticals position peaked at $71.9K in Q4 2024.
26 funds tracked by Wall St. Rank held Tonix Pharmaceuticals as of Q1 2025.

Based on PFG Investments's 13F filing for Q1 2025, filed 22 Apr 2025.